Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-β activation

Biochemical and Biophysical Research Communications

Volumn 422, Issue 3, 2012, Pages 488-493

  Bailey DuBose, Kimberly ^a,c   Zayzafoon, Majd ^b   Murphy Ullrich, Joanne E ^b  

^a and Radiation Oncology   (United States)

^b University of Alabama at Birmingham   (United States)

^c Medtronic   (United States)

Author keywords

Mesenchymal stem cell; Osteoblast; Thrombospondin 1; Transforming growth factor

Indexed keywords

ALKALINE PHOSPHATASE; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; HUMANS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PEPTIDES; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

EID: 84861937821     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.020     Document Type: Article

References (42)

1. Massague J. The transforming growth factor-beta family. Annual Review of Cell and Developmental Biology 1990, 6:597-6641.
2. Janssens K., ten Dijke P., Janssens S., Van Hul W. Transforming growth factor-beta1 to the bone. Endocrine Reviews 2005, 26:743-774.
3. Bonewald D.S. Role of active and latent transforming growth factor beta in bone formation. Journal of Cellular Biochemistry 1994, 55:350-357.
4. Roelen D.P. Controlling mesenchymal stem cell differentiation by TGF-beta family members. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 2003, 8:740-748.
5. Breen E.C., Ignotz R.A., McCabe L., Stein J.L., Stein G.S., Lian J.B. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. Journal of Cellular Physiology 1994, 160:323-335.
6. Zhou S. TGF-beta regulates beta-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. Journal of Cellular Biochemistry 2011, 112:1651-1660.
7. Arita N.A., Pelaez D., Cheung H.S. Activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) is needed for the TGF-beta-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells. Biochemical and Biophysical Research Communications 2011, 405:564-569.
8. Ruan M., Pederson L., Bradley E.W., Bamberger A.M., Oursler M.J. Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis. Endocrinology 2010, 151:1713-1722.
9. Gingery A., Bradley E.W., Pederson L., Ruan M., Horwood N.J., Oursler M.J. TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Experimental Cell Research 2008, 314:2725-2738.
10. Futakuchi M., Nannuru K.C., Varney M.L., Sadanandam A., Nakao K., Asai K., Shirai T., Sato S.Y., Singh R.K. Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Science 2009, 100:71-81.
11. Sato S., Futakuchi M., Ogawa K., Asamoto M., Nakao K., Asai K., Shirai T. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment. Cancer Science 2008, 99:316-323.
12. Juarez P., Guise T.A. Tgf-Beta pathway as a therapeutic target in bone metastases. Current Pharmaceutical Design 2010, 16:1301-1312.
13. Edwards J.R., Nyman J.S., Lwin S.T., Moore M.M., Esparza J., O'Quinn E.C., Hart A.J., Biswas S., Patil C.A., Lonning S., Mahadevan-Jansen A., Mundy G.R. Inhibition of TGF-beta signaling by 1D11 antibody treatment increases bone mass and quality in vivo. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 2010, 25:2419-2426.
14. Takeuchi K., Abe M., Hiasa M., Oda A., Amou H., Kido S., Harada T., Tanaka O., Miki H., Nakamura S., Nakano A., Kagawa K., Yata K., Ozaki S., Matsumoto T. Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth. PLoS One 2010, 5:e9870.
15. Chauhan D., Kharbanda S., Ogata A., Urashima M., Teoh G., Robertson M., Kufe D.W., Anderson K.C. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 1997, 89:227-234.
16. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGF beta activation. Journal of Cell Science 2003, 116:217-224.
17. Wipff P.J., Hinz B. Integrins and the activation of latent transforming growth factor beta1-an intimate relationship. European Journal of Cell Biology 2008, 87:601-615.
18. Sweetwyne M.T., Murphy-Ullrich J.E. Thrombospondin-1 in tissue repair and fibrosis: TGF-beta-dependent and independent mechanisms. Matrix Biology: Journal of the International Society for Matrix Biology 2012, 31:178-186.
19. Adams J.C., Lawler J. The thrombospondins. International Journal of Biochemistry & Cell Biology 2004, 36:961-968.
20. Adams J.C., Lawler J. The thrombospondins. Cold Spring Harbor Perspectives in Biology 2011, 3:a009712.
21. Murphy-Ullrich J.E., Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine & Growth Factor Reviews 2000, 11:59-69.
22. Young G.D., Murphy-Ullrich J.E. Molecular interactions that confer latency to transforming growth factor-beta. Journal of Biological Chemistry 2004, 279:38032-38039.
23. Schultz-Cherry S., Chen H., Mosher D.F., Misenheimer T.M., Krutzsch H.C., Roberts D.D., Murphy-Ullrich J.E. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin-1. Journal of Biological Chemistry 1995, 270:7304-7310.
24. van den Bos T., Speijer D., Bank R.A., Bromme D., Everts V. Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: special emphasis on collagen. Bone 2008, 43:459-468.
25. Ueno A., Miwa Y., Miyoshi K., Horiguchi T., Inoue H., Ruspita I., Abe K., Yamashita K., Hayashi E., Noma T. Constitutive expression of thrombospondin-1 in MC3T3-E1 osteoblastic cells inhibits mineralization. Journal of Cellular Physiology 2006, 209:322-332.
26. Sherbina N.V., Bornstein P. Modulation of thrombospondin gene expression during osteoblast differentiation in MC3T3-E1 cells. Bone 1992, 13:197-201.
27. Alford A.I., Hankenson K.D. Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 2006, 38:749-757.
28. Malaval L., Modrowski D., Gupta A.K., Aubin J.E. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. Journal of Cellular Physiology 1994, 158:555-572.
29. de Oliva M.A., Maximiano W.M., de Castro L.M., da Silva P.E., Fernandes R.R., Ciancaglini P., Beloti M.M., Nanci A., Rosa A.L., de Oliveira P.T. Treatment with a growth factor-protein mixture inhibits formation of mineralized nodules in osteogenic cell cultures grown on titanium. Journal of Histochemistry and Cytochemistry 2009, 57:265-276.
30. de Oliveira P.T., de Oliva M.A., Maximiano W.M., Sebastiao K.E., Crippa G.E., Ciancaglini P., Beloti M.M., Nanci A., Rosa A.L. Effects of a mixture of growth factors and proteins on the development of the osteogenic phenotype in human alveolar bone cell cultures. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 2008, 56:629-638.
31. Gelse K., Klinger P., Koch M., Surmann-Schmitt C., von der Mark K., Swoboda B., Hennig F.F., Gusinde J. Thrombospondin-1 prevents excessive ossification in cartilage repair tissue induced by osteogenic protein-1. Tissue Engineering Part A 2011, 17:2101-2112.
32. Lawler J., Sunday M., Thibert V., Duquette M., George E.L., Rayburn H., Hynes R.O. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. Journal of Clinical Investigation 1998, 101:982-992.
33. Hankenson K.D., Sweetwyne M.T., Shitaye H., Posey K.L. Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling. Current Osteoporosis Reports 2010, 8:68-76.
34. Schultz-Cherry S., Murphy-Ullrich J.E. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. Journal of Cell Biology 1993, 122:923-932.
35. Aubin J.E. Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. Journal of Cellular Biochemistry 1999, 72:396-410.
36. Zayzafoon M., Gathings W.E., McDonald J.M. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology 2004, 145:2421-2432.
37. Abe M., Harpel J.G., Metz C.N., Nunes I., Loskutoff D.J., Rifkin D.B. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Analytical Biochemistry 1994, 216:276-284.
38. Robey P.G., Young M.F., Fisher L.W., McClain T.D. Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. Journal of Cell Biology 1989, 108:719-727.
39. Canfield A.E., Sutton A.B., Hoyland J.A., Schor A.M. Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro. Journal of Cell Science 1996, 109(2):343-353.
40. Alliston T., Choy L., Ducy P., Karsenty G., Derynck R. TGF-beta-induced repression of CBFA1 by Smad 3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO Journal 2001, 20:2254-2272.
41. de Gorter D.J., van Dinther M., Korchynskyi O., ten Dijke P. Biphasic effects of transforming growth factor beta on bone morphogenetic protein-induced osteoblast differentiation. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 2011, 26:1178-1187.
42. Quante M., Tu S.P., Tomita H., Gonda T., Wang S.S., Takashi S., Baik G.H., Shibata W., Diprete B., Betz K.S., Friedman R., Varro A., Tycko B., Wang T.C. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011, 19:257-272.